Using TSCRE, we found CD70 was regulated by a distal enhancer (‘Pair_41_CRE330’) in kidney cancer, which were further validated by FANTOME5 enhancers and pan-cancer ATAC-seq links (Figure 3A). Here, CD70 is linked to cancer.